XML 16 R6.htm IDEA: XBRL DOCUMENT v3.24.3
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net income $ 220,567 $ 242,978
Adjustments to reconcile net income to cash flows from operating activities:    
Depreciation and amortization 21,686 56,386
Share-based compensation expense 75,889 75,062
Deferred income taxes 32,313 (47,385)
Gain on sale of the Athlone Facility (1,462)  
Other non-cash charges 4,794 1,394
Changes in assets and liabilities:    
Receivables (34,734) (49,730)
Contract assets (2,263) 6,163
Inventory (6,051) (9,866)
Prepaid expenses and other assets 1,892 3,947
Right-of-use assets 5,384 12,685
Accounts payable and accrued expenses (82,978) 20,958
Accrued sales discounts, allowances and reserves 18,377 (13,649)
Contract liabilities (2,435) (5,724)
Operating lease liabilities (7,594) (12,569)
Other long-term liabilities 5,342 13,466
Cash flows provided by operating activities 248,727 294,116
CASH FLOWS FROM INVESTING ACTIVITIES:    
Additions of property, plant and equipment (23,711) (31,018)
Proceeds from the sale of equipment 454 6
Proceeds from the sale of the Athlone Facility 97,933  
Purchases of investments (396,895) (186,593)
Sales and maturities of investments 224,786 291,944
Cash flows (used in) provided by investing activities (97,433) 74,339
CASH FLOWS FROM FINANCING ACTIVITIES:    
Proceeds from the issuance of ordinary shares under share-based compensation arrangements 19,354 15,113
Employee taxes paid related to net share settlement of equity awards (29,293) (26,080)
Payment for the repurchase of ordinary shares (200,281)  
Principal payments of long-term debt (2,250) (2,250)
Cash flows used in financing activities (212,470) (13,217)
NET (DECREASE) INCREASE IN CASH AND CASH EQUIVALENTS (61,176) 355,238
CASH AND CASH EQUIVALENTS—Beginning of period 457,469 292,473
CASH AND CASH EQUIVALENTS—End of period 396,293 647,711
Non-cash investing and financing activities:    
Purchased capital expenditures included in accounts payable and accrued expenses $ 3,053 $ 4,209